Wells Fargo’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$122K Buy
2025
Q1
$134K Buy
2024
Q4
$255K Buy
2024
Q3
$182K Buy
2024
Q2
$155K Buy
2024
Q1
$108K Buy
2023
Q4
$100K Buy
2023
Q3
$84.2K Sell
2023
Q2
$124K Buy
2023
Q1
$2.45K Buy
2022
Q4
$2.27K Buy
2022
Q3
$3K Buy
2022
Q2
$2K Sell
2022
Q1
$21K Sell
2021
Q4
$91K Buy